source
- Caribou Biosciences explores strategic alternatives, drawing interest as a reverse-merger candidateCaribou Biosciences, the cell‑therapy company co‑founded by CRISPR pioneer Jennifer Doudna, announced it is evaluating strategic alternatives as it faces a difficult financing environment. The com…
- HHS unveils new vaccine injury surveillance plan with NIH clinic and reporting reimbursementsThe Department of Health and Human Services announced a comprehensive initiative to improve monitoring of vaccine-related injuries. The plan includes opening a new clinic at the National Institute…